Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis (HLH) is a clinical syndrome associated with hereditary or acquired immune-dysregulation. HLH is classified into either primary or secondary disease based on whether or not clear genetic defects are present. Patients of primary HLH have clear hereditary or genetic